|
Volumn 67, Issue 3, 2000, Pages 659-662
|
Pharmacological identification of SM-21, the novel σ2 antagonist
|
Author keywords
2 Receptor subtype; AC927; DTG; Neck dystonia; Red nucleus; SM 21
|
Indexed keywords
1,3 BIS(2 METHYLPHENYL)GUANIDINE;
3ALPHA TROPANYL 2 (4 CHLOROPHENOXY)BUTYRIC ACID;
AC 927;
GUANIDINE DERIVATIVE;
OPIATE ANTAGONIST;
PHENETHYLPIPERIDINE;
SIGMA 2 OPIATE RECEPTOR ANTAGONIST;
SM 21;
TROPANE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG POTENCY;
DRUG SELECTIVITY;
DYSTONIA;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
RECEPTOR AFFINITY;
RED NUCLEUS;
TORTICOLLIS;
ANALGESICS;
ANIMALS;
ANTICONVULSANTS;
BUTYRATES;
GUANIDINES;
MALE;
RATS;
RATS, WISTAR;
RECEPTORS, SIGMA;
RED NUCLEUS;
TORTICOLLIS;
TROPANES;
|
EID: 0034491018
PISSN: 00913057
EISSN: None
Source Type: Journal
DOI: 10.1016/S0091-3057(00)00405-6 Document Type: Article |
Times cited : (31)
|
References (24)
|